Gene therapy approaches for cardiovascular diseases

Area of Science:

• Cardiovascular research
• Gene therapy applications
• Regenerative medicine

Background:

• Cardiovascular diseases (CVDs) are a leading cause of mortality in Western nations.
• Gene therapy is an emerging treatment strategy for various CVDs, including peripheral arterial disease and ischemic heart disease.
• Significant advancements in gene transfer have led to ongoing human clinical trials.

Purpose of the Study:

• To provide an overview of gene transfer strategies for cardiovascular diseases.
• To highlight current delivery routes and vectors used in animal studies and clinical trials.
• To focus on novel approaches like combined gene and cell therapy, gene silencing, and targeted gene delivery.

Main Methods:

• Review of existing gene transfer strategies.
• Analysis of delivery routes and vectors in preclinical and clinical studies.
• Exploration of emerging techniques such as gene silencing and targeted gene delivery.

Main Results:

• Gene therapy has shown remarkable progress over the past decade.
• Various delivery routes and vectors are being utilized in animal models and human trials.
• New approaches are being developed for gene targeting to the vascular wall and myocardium.

Conclusions:

• Gene therapy holds significant potential for treating cardiovascular diseases.
• Combination therapies involving gene therapy, cell therapy, and tissue engineering are promising.
• Advanced techniques for gene silencing and targeted delivery represent the future of cardiovascular gene therapy.